Material Group inc. Logo

Material Group inc.

A professional services firm offering PR consulting, marketing, and brand strategy.

156A | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区赤坂一丁目12番32号アーク森ビル35階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Material Group Inc. is a professional services firm that offers comprehensive marketing and communications support, with a core focus on PR consulting. The company operates as a collective of specialized businesses that collaborate to provide tailored solutions for a diverse range of clients. Its services include brand strategy analysis, market research, and business marketing, all aimed at maximizing the potential of clients' brands, products, and services. In March 2024, Material Group was listed on the Tokyo Stock Exchange's Growth Market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-09 08:39
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.7 KB
2025-05-15 10:10
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.3 KB
2025-04-14 08:31
Regulatory News Service
確認書
Japanese 8.1 KB
2025-04-14 08:30
Interim Report
半期報告書-第12期(2024/09/01-2025/08/31)
Japanese 197.5 KB
2024-12-02 07:32
Regulatory News Service
訂正臨時報告書
Japanese 32.7 KB
2024-11-28 07:32
Post-Annual General Meeting Information
臨時報告書
Japanese 23.1 KB
2024-11-28 07:31
Governance Information
内部統制報告書-第11期(2023/09/01-2024/08/31)
Japanese 23.6 KB
2024-11-28 07:31
Registration Form
確認書
Japanese 8.1 KB
2024-11-28 07:30
Annual Report
有価証券報告書-第11期(2023/09/01-2024/08/31)
Japanese 1.9 MB
2024-11-27 07:30
Earnings Release
臨時報告書
Japanese 18.4 KB
2024-07-12 08:01
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-07-12 08:01
Quarterly Report
四半期報告書-第11期第3四半期(2024/03/01-2024/05/31)
Japanese 144.7 KB
2024-04-30 08:14
Major Shareholding Notification
臨時報告書
Japanese 20.3 KB
2024-04-12 08:03
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-04-12 08:02
Quarterly Report
四半期報告書-第11期第2四半期(2023/12/01-2024/02/29)
Japanese 168.5 KB

Automate Your Workflow. Get a real-time feed of all Material Group inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Material Group inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway PCIB

Talk to a Data Expert

Have a question? We'll get back to you promptly.